Anesthetic and ICU Management of Living Donor Liver Transplant
Donor Selection and Preoperative Evaluation
Living donor liver transplantation should be performed exclusively at high-volume centers with established protocols for comprehensive donor evaluation 1. The donor evaluation must include liver anatomical, parenchymal, and volumetric assessment with a mandatory liver remnant of at least 30% of pre-donation volume 1. Screen for silent comorbidities including MASLD, cardiovascular disease, procoagulant conditions, and psychosocial risk factors 1.
Anesthetic Management
Preoperative Preparation
- Avoid long-acting anxiolytics, particularly in elderly donors; short-acting agents like 1-2 mg midazolam may be used selectively 2
- Fasting protocol: 2 hours for clear liquids, 6 hours for solids 2
- Carbohydrate loading the evening before and 2-4 hours before induction reduces insulin resistance 2
- Antibiotic prophylaxis (cefazolin) within 60 minutes of incision 2
- Methylprednisolone 500 mg administration is recommended 2
Intraoperative Anesthetic Technique
Total intravenous anesthesia with propofol and sufentanil is the preferred approach 3. Induction with propofol 300 mL/h and sufentanil 0.3 mcg/kg, with cisatracurium 0.15 mg/kg for intubation 3. Maintenance with oxygen 40% in air, isoflurane 1-1.5 MAC, and sufentanil 3.
For donor anesthesia, sevoflurane should be strongly considered over desflurane, as the most recent high-quality evidence demonstrates that donor sevoflurane anesthesia significantly reduces recipient post-reperfusion syndrome (64.0% vs 71.8%, p<0.001) and is an independent protective factor (OR 0.47) 4. This represents a critical finding that directly impacts recipient morbidity and mortality.
Monitoring Requirements
Essential monitoring includes:
- Invasive arterial blood pressure
- Central venous pressure
- Pulse oximetry and capnography
- Core temperature monitoring
- Neuromuscular blockade monitoring
- Urine output 3
Advanced monitoring with cerebral oximetry may be considered in complex cases 5.
Fluid and Hemodynamic Management
Maintain restrictive fluid strategy with goal-directed therapy 5. Use crystalloids, colloids, and 4% albumin as needed 3. Target central venous pressure should be kept low during parenchymal transection to minimize blood loss 6.
Maintain normothermia using multimodal temperature management including circulating water garments or forced warm air 2. All donors should be normothermic by end of surgery 3.
Blood Conservation Strategy
Living donor hepatectomy should be performed without homologous blood transfusion 7. Implement:
- Cell salvage technology
- Autologous blood transfusion when needed
- Meticulous surgical hemostasis
- Goal-directed coagulation management 5
Average blood loss ranges 550-1600 mL, which is typically well-tolerated without transfusion 3.
Analgesia Management
For open donor hepatectomy, continuous local anesthetic wound infiltration via wound catheter is preferred over thoracic epidural analgesia 2. Wound catheters provide equivalent analgesia with lower complication rates and avoid the mobility issues and hypotension associated with epidurals 2.
Multimodal analgesia is mandatory, potentially including:
- Continuous wound infiltration catheters 2
- Transversus abdominis plane (TAP) blocks to supplement standard analgesia 2
- Acetaminophen (dose-adjusted for extent of resection) 2
- Judicious IV opiates 2
Avoid preoperative gabapentinoids and NSAIDs 2.
Critical Epidural Considerations
If epidural analgesia is used (though not preferred), recognize that PT and INR become significantly elevated postoperatively, reaching maximum on Day 1 (PT 16.9±2.5 s, INR 1.4±0.2) 7. Despite this, epidural hematoma has not been reported when careful monitoring guides catheter removal timing 7. However, the hemodynamic disadvantages and mobility impairment make this technique suboptimal for enhanced recovery 2.
Postoperative ICU Management
Immediate Postoperative Care
Target immediate extubation in the operating room or within 5-25 hours in ICU 3. Four of eight donors in one series were extubated immediately post-surgery 3.
Avoid prophylactic nasogastric intubation - it offers no benefit and may increase length of stay 2.
Do not place routine abdominal drains for hepatectomy without biliary reconstruction 2.
Metabolic Monitoring and Replacement
Hypophosphatemia and hypomagnesemia are frequent and require aggressive replacement 7:
- Magnesium levels decline to 1.05±0.18 mg/dL on Day 1
- Phosphorus levels decline to 2.3±0.83 mg/dL on Day 3
- Monitor and replace electrolytes proactively 7
Maintain normoglycemia (<8.3 mmol/L) with insulin therapy 2.
Coagulation Management
Monitor coagulation parameters closely:
- PT/INR peaks on postoperative Day 1
- Liver function tests transiently elevate initially 3
- Hemoglobin typically drops from ~13.6 to ~10.5 g/dL immediately post-op, recovering to ~11.7 g/dL by Day 1 3
Nutrition and Early Recovery
Implement early oral intake with normal diet immediately after hepatectomy 2. Enteral nutrition is preferred over parenteral if artificial nutrition is required 2.
Consider postoperative laxatives, gum chewing, or herbal medicine to stimulate bowel movement 2.
Thromboprophylaxis
Initiate low molecular weight heparin or unfractionated heparin postoperatively unless contraindicated 2. Combine with intermittent pneumatic compression devices 2.
Expected Outcomes and Complications
Typical ICU stay is 1-3 days with hospital discharge at 7-17 days 3. The morbidity rate approaches 50%, with most common complications being:
- Infection/intraabdominal collections (21.1%)
- Biliary leak (18.2%) 7
Major complications including portal vein thrombosis and mortality, while rare, can occur 7. The procedure is definitively not complication-free, and all risks must be disclosed during consent 7.
Enhanced Recovery After Surgery (ERAS) Protocol
Implement comprehensive ERAS protocols including:
- Preoperative counseling and optimization
- Minimally invasive techniques when appropriate 2
- Multimodal analgesia without epidural
- Early mobilization (avoid epidural-related mobility issues)
- Early oral nutrition
- Restrictive fluid management
- Avoidance of routine tubes and drains 2, 6
The combination of these evidence-based interventions reduces complications and shortens hospital stay 2.